Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)
Clinical trial NCT03964558 · COMPLETED
Trial details
- NCT number
- NCT03964558
- Sponsor
- Celtaxsys, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2019-04-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.